Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy

Anne Angelillo‐Scherrer(Geneva College), Laurent Burnier(University Hospital of Geneva), Nathalie Flores(University Hospital of Geneva), Pierre Savi, Maria DeMol, Paul Schaeffer, Jean-Marc Herbert, Greg Lemke(Salk Institute for Biological Studies), Stephen P. Goff(Columbia University), Glenn K. Matsushima(Center for Neurosciences), H. Shelton Earp(University of North Carolina at Chapel Hill), Christian Vesin(University of Geneva), Marc Hoylaerts, Stéphane Plaisance, Désiré Collen, Edward M. Conway, Bernhard Wehrle‐Haller(University of Geneva), Peter Carmeliet
Journal of Clinical Investigation
January 13, 2005
Cited by 259Open Access
Full Text

Abstract

Mechanisms regulating thrombus stabilization remain largely unknown. Here, we report that loss of any 1 of the Gas6 receptors (Gas6-Rs), i.e., Tyro3, Axl, or Mer, or delivery of a soluble extracellular domain of Axl that traps Gas6 protects mice against life-threatening thrombosis. Loss of a Gas6-R does not prevent initial platelet aggregation but impairs subsequent stabilization of platelet aggregates, at least in part by reducing "outside-in" signaling and platelet granule secretion. Gas6, through its receptors, activates PI3K and Akt and stimulates tyrosine phosphorylation of the beta3 integrin, thereby amplifying outside-in signaling via alphaIIbbeta3. Blocking the Gas6-R-alphaIIbbeta3 integrin cross-talk might be a novel approach to the reduction of thrombosis.


Related Papers